Vimarsana
Biggest News Aggregation in the World

Page 4 - Endocrine Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endocrine Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endocrine Practice Today - Breaking & Trending Today

Kelp Benefits 2022: The Oceanic Plant That Can Boost Your Health - Vimarsana News

Kelp Benefits 2022: The Oceanic Plant That Can Boost Your Health

Sea kelp is a food product that reaches our kitchen from the oceans as a source of iodine and fiber. Let's take a look at kelp benefits 2023.

Estrogen Protective Against COVID Death; New NAFLD Guidance; At-Home HbA1c Testing - Vimarsana News

Estrogen Protective Against COVID Death; New NAFLD Guidance; At-Home HbA1c Testing

News and commentary from the endocrinology world

Sleep and the Covid-19 Pandemic | naked capitalism - Vimarsana News

Sleep and the Covid-19 Pandemic | naked capitalism

An unsystematic survey of the effect of SARS-COV-2, the virus, on sleeping individuals; and the effect of COVID-19, the disease, on populations.

FDA Eyes Oral Testosterone; Phase II Success for Novel Osteoporosis Tx - Vimarsana News

FDA Eyes Oral Testosterone; Phase II Success for Novel Osteoporosis Tx

email article The FDA accepted a new drug application and set a review date of October 31 for Marius Pharmaceuticals' Kyzatrex, an oral testosterone undecanoate softgel, for primary and secondary male hypogonadism. The Endocrine Society released a new scientific statement calling for more research into the sex differences between males and females. ( Endocrine Reviews) The American Medical Association has recognized a CPT code (category III) for laser ablation of benign thyroid nodules under imaging guidance, going into effect January 2022, National Ultrasound announced. Entera Bio's or...

Rare Metabolic Disorder Tx OK'd; Fertility Nurse Pleads Guilty - Vimarsana News

Rare Metabolic Disorder Tx OK'd; Fertility Nurse Pleads Guilty

email article The FDA approved fosdenopterin (Nulibry) -- the first specific treatment for the rare metabolic disorder molybdenum cofactor deficiency type A. Hospitalized COVID-19 patients with low free T3 levels saw significantly higher rates of mortality, mechanical ventilation, and ICU admission. ( Endocrine Practice) Almost a quarter of patients with kidney stone disease also had osteoporosis or a fracture, according to a study of over 500,000 people. ( Journal of Bone and Mineral Research) In related news, women with primary ovarian insufficiency who experience early menopause ha...